Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
Provided By GlobeNewswire
Last update: Oct 23, 2025
CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology’s (ACR) annual meeting, ACR Convergence 2025, being held October 24-29, 2025, at the McCormick Place Convention Center in Chicago, Illinois.
Read more at globenewswire.com
